O'Neil Thomas P.
Chief Financial Officer at Satsuma Pharmaceuticals, Inc.; Chief Financial Officer at PTGX
- Sold, on record
- $406k
- Dollars the filings state
- Form 4 sales
- 8
- Latest Sep 1, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Satsuma Pharmaceuticals, Inc.Chief Financial Officer
- PTGXProtagonist Therapeutics, IncChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Satsuma Pharmaceuticals, Inc.8,865 shares
- PTGX8,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale PTGXUnusualDec 18, 2017 2017
Sold 8,000 shares at $20.00 ($160k)
O'Neil Thomas P., Chief Financial Officer
Sold 100% of holdings ($160k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Satsuma Pharmaceuticals, Inc.UnusualMar 11, 2020 +814 days
Sold 1,000 shares at $27.68 ($28k)
O'Neil Thomas P., Chief Financial Officer
Sold 100% of holdings ($28k position)0 shares leftFirst sale on recordFiling
- 3 Form 4 sale Satsuma Pharmaceuticals, Inc.UnusualMay 20, 2020 +70 days
Sold 2,000 shares at $25.00 ($50k)
O'Neil Thomas P., Chief Financial Officer
Sold 100% of holdings ($50k position)0 shares leftFiling
- 4 Form 4 sale Satsuma Pharmaceuticals, Inc.UnusualJun 1, 2020 +12 days
Sold 1,000 shares at $25.32 ($25k)
O'Neil Thomas P., Chief Financial Officer
Sold 100% of holdings ($25k position)0 shares leftFiling
- 5 Form 4 sale Satsuma Pharmaceuticals, Inc.UnusualJun 23, 2020 +22 days
Sold 2,115 shares at $35.23 ($75k)
O'Neil Thomas P., Chief Financial Officer
Sold 100% of holdings ($75k position)0 shares left2.1x usual sizeFiling
- 6 Form 4 sale Satsuma Pharmaceuticals, Inc.UnusualJul 1, 2020 +8 days
Sold 1,000 shares at $26.65 ($27k)
O'Neil Thomas P., Chief Financial Officer
Sold 100% of holdings ($27k position)0 shares left0.7x usual sizeFiling
- 7 Form 4 sale Satsuma Pharmaceuticals, Inc.UnusualAug 5, 2020 +35 days
Sold 1,000 shares at $25.00 ($25k)
O'Neil Thomas P., Chief Financial Officer
Sold 100% of holdings ($25k position)0 shares left1x usual sizeFiling
- 8 Form 4 sale Satsuma Pharmaceuticals, Inc.UnusualSep 1, 2020 +27 days
Sold 750 shares at $22.19 ($17k)
O'Neil Thomas P., Chief Financial Officer
Sold 100% of holdings ($17k position)0 shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2020 | Sep 3, 2020 | Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 750 | $17k | 100.0% | Unusual | SEC |
| Aug 5, 2020 | Aug 7, 2020 | Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,000 | $25k | 100.0% | Unusual | SEC |
| Jul 1, 2020 | Jul 2, 2020 | Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,000 | $27k | 100.0% | Unusual | SEC |
| Jun 23, 2020 | Jun 24, 2020 | Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 2,115 | $75k | 100.0% | Unusual | SEC |
| Jun 1, 2020 | Jun 2, 2020 | Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,000 | $25k | 100.0% | Unusual | SEC |
| May 20, 2020 | May 21, 2020 | Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 2,000 | $50k | 100.0% | Unusual | SEC |
| Mar 11, 2020 | Mar 12, 2020 | Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,000 | $28k | 100.0% | Unusual | SEC |
| Dec 18, 2017 | Dec 20, 2017 | PTGX | Chief Financial Officer | Form 4 sale | 8,000 | $160k | 100.0% | Unusual | SEC |